Anna Schurich

We aim to design aptamer-directed CARs (aCARs) to improve targeting and activation of CAR-T cells against solid tumors. Using human donor-derived T cells, we will engineer aCARs and assess their ability to trigger effector functions and tumor killing through phenotypic, metabolic, and functional profiling in established in vitro co-culture assays.